Group 1: Company Overview and Strategy - The company plans to adopt an omnichannel approach, including hospitals, pharmacies, and e-commerce channels for sales [3] - Future product line extensions will involve introducing new varieties, agency agreements, and OEM partnerships [3] - The brand "客药嘉应" aims to position the company as the leading player in the Hakka traditional medicine market [3] Group 2: Sales and Product Performance - The company reported that major products' sales details are available in periodic reports [4] - The dual strategy for "双料喉风散" and "接骨七厘片" will continue, with confidence in improved performance in future procurement cycles [4] Group 3: Financial Outlook and Collaborations - The company has set performance targets for the next three years in its employee stock ownership plan [4] - "养天和" holds a 7% stake and aims to enhance control over the company while exploring mergers and acquisitions to support core business development [4]
嘉应制药(002198) - 嘉应制药投资者关系管理信息